
VIVOS INC
OTC · Surgical & Medical Instruments & Apparatus
Company Overview
A concise company profile alongside the latest public filing activity.
Vivos Inc. (RDGL) develops radiopharmaceutical and biotechnology products, including its RadioGel brachytherapy device, which delivers radiation directly into solid tumors to treat cancer. The company is based in Richland, Washington.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Korenko Michael KCEO | Buy | $10K | 200,000at $0.05 | Nov 20, 2026 |
| Weeks Brad AllanPresident | Buy | $6K | 150,000at $0.04 | Nov 20, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable RDGL activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.